terazol® 7 vaginal cream 0.4% (terconazole) terazol® 3 vaginal cream 0.8% (terconazole) terazol® 3 vagina
janssen pharmaceuticals, inc. - terconazole (unii: 0kj2ve664u) (terconazole - unii:0kj2ve664u) - terconazole 4 mg in 1 g - terazol® 7 (terconazole) vaginal cream 0.4%, terazol® 3 (terconazole) vaginal cream 0.8% and terazol® 3 (terconazole) vaginal suppositories 80 mg are indicated for the local treatment of vulvovaginal candidiasis (moniliasis). as these products are effective only for vulvovaginitis caused by the genus candida, the diagnosis should be confirmed by koh smears and/or cultures. patients known to be hypersensitive to terconazole or to any of the components of the cream or suppositories.
terazol® 5 cream
janssen -
terazol 7 vaginal cream 0.4%
janssen inc - terconazole - cream - 4mg - terconazole 4mg - azoles
terazol 3 dual pak ovule
janssen inc - terconazole; terconazole - ovule - 0.8%; 80mg - terconazole 0.8%; terconazole 80mg - azoles
gyno-terazol 15g crm
ethnor - terconazole - crm - 0.8%w/w - 15g
gyno-terazol ovules 3
ethnor - terconazole - 80mg - 3
terazol pessary 80 milligram
cilag limited - terconazole - pessary - 80 milligram
terazol cream 0.4 per cent
cilag limited - terconazole - cream - 0.4 per cent
terazol cream 0.8 per cent
cilag limited - terconazole - cream - 0.8 per cent
terazol pessary 240 milligram
cilag limited - terconazole - pessary - 240 milligram